The risk of female malignancies after fertility treatments: a cohort study with 25-year follow-up
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00432-015-2035-x.pdf
Reference27 articles.
1. Bernstein L (2002) Epidemiology of endocrine-related risk factors for breast cancer. J Mammary Gland Biol Neoplasia 7:3–15
2. Boivin J, Bunting L, Collins JA, Nygren KG (2007) International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Hum Reprod 22:1506–1512
3. Brinton LA, Lamb EJ, Moghissi KS, Scoccia B, Althuis MD, Mabie JE et al (2004a) Ovarian cancer risk associated with varying causes of infertility. Fertil Steril 82:405–414
4. Brinton LA, Lamb EJ, Moghissi KS, Scoccia B, Althuis MD, Mabie JE et al (2004b) Ovarian cancer risk after the use of ovulation-stimulating drugs. Obstet Gynecol 103:1194–1203
5. Brinton LA, Westhoff CL, Scoccia B, Lamb EJ, Trabert B, Niwa S et al (2013) Fertility drugs and endometrial cancer risk: results from an extended follow-up of a large infertility cohort. Hum Reprod 28:2813–2821
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The risk of endocrine interventions in carriers of a genetic predisposition for breast and gynecologic cancers: recommendations of the German Consortium for Hereditary Breast and Ovarian Cancer;Journal of Cancer Research and Clinical Oncology;2024-09-11
2. Fertility drugs and cancer: a guideline;Fertility and Sterility;2024-09
3. Epidemiological trends and risk factors of gynecological cancers: an update;Medical Oncology;2023-02-09
4. Ovulation induction drug and ovarian cancer: an updated systematic review and meta-analysis;Journal of Ovarian Research;2023-01-24
5. The Relationship between Assisted Reproductive Technology IVF-ET and the Incidence of Gynecological Ovarian Tumors and the Position and Significance of the Intervention of Traditional Chinese Medicine;Traditional Chinese Medicine;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3